ARTICLE | Clinical News
Elelyso regulatory update
June 9, 2014 7:00 AM UTC
Protalix said Health Canada approved Elelyso taliglucerase alfa for long-term enzyme replacement therapy in adults and pediatric patients with Type 1 Gaucher's disease. The company said Elelyso may al...